Very little is known of the antibiotic resistance mechanisms of members of the Chromobacterium genus. In previous studies of Chromobacterium subtsugae (formerly C. violaceum) strain CV017, we identified a resistance nodulation division (RND)-family efflux pump (CdeAB-OprM). Here, we show the cdeAB-oprM genes are widely distributed in members of the Chromobacterium genus. We use antimicrobial susceptibility testing with a CV017 cdeAB-oprM mutant to show the products of these genes confers resistance to a variety of antibiotics including ciprofloxacin, a clinically important antibiotic. We also identified a related RND-family pump, cseAB-oprN, in the genome of CV017 and other C. subtsugae species, that is not present in other members of the Chromobacterium genus.
INTRODUCTION
Members of the Chromobacterium genus are often found in water and soil environments of tropical and subtropical regions (1) . The best-studied member, Chromobacterium violaceum, can cause occasional but often fatal infections in patients (2) . C. violaceum and other members of this genus are also potentially useful in industry and ecological applications. C. violaceum has been shown to synthesize bioplastics (3, 4) , hydrolyze plastic films (5) , and solubilize gold (6, 7) .
C. violaceum and some other members of this genus can also kill insects and might be potentially useful in pest management (8, 9) . The most well-known trait shared by many members of this genus is the ability to produce a purple pigment, violacein, which has a variety of biotechnologically interesting applications including as an antimicrobial (10) and anti-cancer therapeutic (11, 12) . Production of violacein and other antibiotics is controlled by Nacylhomoserine lactone quorum sensing (13, 14) , a type of cell-cell communication distributed widely in the Proteobacteria (15) . Because production of violacein can be easily observed in cell cultures, a strain of C. subtsugae strain CV017 (formerly C. violaceum CV017) was developed for use as a biosensor of N-acyl homoserine lactone signals from the environment and other bacteria (13) .
CV017 was also used in a dual-species laboratory model with another soil saprophyte, Burkholderia thailandensis, to understand quorum sensing involvement in antimicrobials production and interspecies competition (16) . B. thailandensis and C. subtsugae can be isolated from similar soil and water environments of tropical regions, however, these were chosen for the co-culture model because they each grow similarly in the conditions of the experiment. Also, each species produces antibiotics that can kill the other species (16) . In B. thailandensis, the antibiotic is bactobolin, which targets the 50S ribosomal subunit to block translation (17) . We showed that an efflux pump in CV017 is important for bactobolin resistance, which we called CdeAB-OprM (18) .
CdeAB-OprM is a predicted resistance nodulation division (RND) efflux pump. Drug efflux pumps are protein complexes which reside in the membrane and transport antimicrobials and toxins from the cytoplasm and periplasm to the extra-cellular space (19) . The RND families are situated within the inner membrane and function in complex with two other proteins, an outer membrane channel and a periplasmic adaptor protein to form a tripartite efflux pump spanning both the inner and the outer membrane (19) . Drug exporters belonging to the RND family play a key role in resistance to clinically relevant antibiotics in Proteobacteria (19) . Resistance to antibiotics is generally due to mutation of an efflux pump regulator that causes an increase in transcription of the efflux pump genes and subsequently increases the antibiotic efflux activity of the pump, causing the cell to become more antibiotic resistant.
In this study, we explore the involvement of CdeAB-OprM in antibiotic resistance and how it is regulated. We show that CdeAB-OprM is involved in resistance to a variety of antibiotic classes and that this system is regulated by CdeR, a repressor of the tetR family. We also identified a new RND-family efflux pump CseAB-OprN, with high similarly to the CdeAB-OprM system. The cseAB-oprN genes are only present in C. subtsugae. We show that although CseABOprN does not appear to be important for antibiotic resistance, it does increase antibiotic tolerance in cells exposed to a sub-lethal antibiotic dose, and that this pump has a high degree of specificity and sensitivity to the B. thailandensis antibiotic bactobolin. The tolerance response relies on a LysR-family regulator encoded adjacent to the cseAB-oprN genes, CseR. Finally, we show that adding a sub-lethal dose of bactobolin to our B. thailandensis-C. subtsugae co-culture model increases the competitiveness of C. subtsugae in a manner dependent on CseAB-OprN and CseR. Together, our results describe two RND-efflux pumps found in members of the Chromobacterium genus and demonstrate how the evolution of antibiotic response might be important during competition with other species in the soil.
RESULTS

Distribution of cdeAB-oprM and cseAB-oprN in Chromobacterium.
We constructed a phylogenetic tree using 32 Chromobacterium genomes and an outgroup
(Aquitaliea magnus) to analyze efflux pump genes in the Chromobacterium genus (Fig. 1A, Fig.   S1 and Table S1 ). We initially used 16S rRNA sequences to construct the tree, however, we could not confidently predict some of the groupings, particularly the relationship of CV017 with other species. Thus, we constructed the tree using a set of 140 orthologous proteins (see Materials and Methods) to increase confidence of relationship predictions. Using this method, CV017 grouped with the C. subtsugae strains, consistent with the new classification of this strain as C. subtsugae.
We were also able to make predictions of species associations for some of the unnamed species, for example, strain F49 grouped with the C. subtsugae clade.
To determine the distribution of the cdeAB-oprM genes in the Chromobacterium genus, we searched for the C. subtsugae CV017 cdeB gene in the 32 Chromobacterium genomes. We identified cdeB homologs in all of the strains, with nucleotide sequence identities ranging from 85-100% to CV017 cdeB. In CV017, cdeB is flanked by a putative periplasmic efflux pump-associated protein (cdeA) and outer membrane component (oprM) (Fig. 1B) , typical of many RND-family efflux pump gene clusters. There was a similar gene arrangement in each of the other Chromobacterium species. We also identified second cdeB homolog in CV017, which we named cseB. cseB has 80% nucleotide identity to cdeB (74% protein sequence identity). cseB is similarly flanked by a cdeA homolog (cseA) and an oprM homolog (oprN). However, there is no apparent regulator encoded upstream of cseA. Instead, we noted a predicted LysR-family regulator encoded downstream of oprN, which we call cseR. We identified cseB homologs only in CV017, F49 and other members of the C. subtsugae species. In these other species, the cseB genes were >99% identical to one another, and the organization of genes surrounding cseB was conserved with that of the cseAB-oprN genes in CV017. We did not identify an apparent cseB homolog in one species of C. subtsugae (MWU2920) or any of the other Chromobacterium strains. We predicted that the cseAB-oprN gene cluster might have arisen from the cdeAB-oprM genes via a duplication event that occurred in an ancestor of C. subtsugae, however, generation of a second tree using the sequences of cseB and cdeB only did not support this hypothesis (Fig.   S2) . Instead, the alignments show cseB groups with cdeB from Chromobacterium species C61, suggesting that it might have arisen from a horizontal gene transfer event from an ancestor of this strain.
Antibiotic susceptibility of cdeAB-oprM and cseAB-oprN mutants.
We previously demonstrated that deleting the cdeAB-oprM genes from CV017 increases susceptibility to the ribosome-targeting antibiotics bactobolin and another ribosome-targeting antibiotic, tetracycline, and the DNA intercalating agent ethidium bromide (18) . These data support the idea that CdeAB-OprM system is an efflux pump that increases resistance to a range of toxic substrates. We sought to characterize the involvement of the CdeAB-OprM pump in resistance to a wider range of antibiotics and similarly characterize the CseAB-OprN system. Thus, we deleted cseB in CV017 and tested susceptibility of the DcseB and DcdeAB-oprM mutants to bactobolin and tetracycline, and other ribosome-targeting antibiotics chloramphenicol, erythromycin (a macrolide), and gentamicin and kanamycin (both aminoglycosides). We also tested imipenem (a cell wall-targeting b-lactam antibiotic), and the DNA gyrase inhibitor ciprofloxacin. The results (Table 1) show that deleting the cdeAB-oprM genes increased susceptibility to erythromycin, chloramphenicol and ciprofloxacin, but not to either of the aminoglycoside antibiotics. Surprisingly, deleting cseB had no effect on susceptibility to any of the antibiotics tested. There was also no effect of deleting cseB in the DcdeAB-oprM mutant.
These results show that CdeAB-OprM increases resistance to a wider range of antibiotics than reported previously, and that CseAB-OprN does not appear to influence resistance of any of these antibiotics in the conditions of our experiments.
CdeR is a CdeAB-OprM repressor.
cdeR is encoded adjacent to the cdeAB-oprM gene cluster and predicted to encode a TetR-family transcriptional regulator, which typically function as transcriptional repressors by binding to the promoters of their target genes (the hallmark of this family, TetR, binds to the promoter of the tetA gene encoding the tetracycline pump) (20) . Previously, we reported a CdeR mutant (CdeR H127Y) that increased transcription of cdeA and cdeB, and also increased bactobolin resistance (18) . These results are consistent with the idea that CdeR is a repressor, and the CdeR H127Y mutation abolishes repressor activity. As further validation that CdeR is a repressor, we deleted cdeR in CV017, and tested the consequence of the deletion on cdeAB transcription and antibiotic susceptibility. Similar to the CdeR H127Y mutation, deleting cdeR increased transcription of cdeA and cdeB (Table 1 and Fig. S3 ). The DcdeR mutant was also more resistant than the CV017 parent to each of the apparent CdeAB-OprM substrates (tetracycline, erythromycin, chloramphenicol and ciprofloxacin, Table 1 ). The DcdeR, DcdeABoprM double mutant was not resistant to these antibiotics, showing MICs similar to that of the DcdeAB-oprM single mutant. Together, these results support that CdeR functions as a specific repressor of cdeAB-oprM transcription.
CseAB-OprN and CdeAB-OprM are important for antibiotic tolerance.
The cseR gene adjacent to cseAB-oprN is also predicted to encode a transcriptional regulator, which belongs to the broadly distributed LysR-type regulator family (21) . Most LysRfamily regulators function as activators and require binding of a ligand, such as an antibiotic, to effectively activate transcription of their target genes (21) . Consistent with the idea that CseR is not a repressor, deleting cseR had no effect on resistance to any of the antibiotics tested (Table   1 ). To test the idea that CseR might be an antibiotic-responsive activator, we developed an experiment to measure changes in antibiotic susceptibility (MIC) after exposure to sublethal antibiotic concentrations, which we call induction of antibiotic tolerance. We incubated CV017 cells with a sub-lethal concentration of antibiotic (1/2 the MIC determined in Table 1 ), then assessed MIC of the treated cells and identically grown untreated cells. We began by testing bactobolin, because efflux pumps are commonly activated by their own antibiotic substrates (19) , and the high relatedness of CseB and CdeB suggest these systems might have overlapping antibiotic specificity. We found that after 6 h of incubation with sub-MIC bactobolin, the MIC of bactobolin-treated cells increased by 3.2 (± 0.2)-fold compared with identically-grown untreated cells ( Fig. 2A) , demonstrating a clear induction of bactobolin tolerance. We performed similar experiments with our DcdeAB-oprM and DcseB mutants. Our results showed sublethal bactobolin increased the MIC of the DcdeAB-oprM mutant similar to wild type. However, the MIC did not increase for the DcseB mutant. These results support that induction of bactobolin tolerance requires CseAB-OprN but not CdeAB-OprM.
To test whether CseAB-OprN is also involved in inducing resistance to other antibiotics, we tested erythromycin, ciprofloxacin, and tetracycline for induction of tolerance. We observed no significant resistance increase after exposure to a sub-lethal erythromycin and ciprofloxacin showed evidence of a small but not significant change (Fig. S4 ). However, exposure to sub-MIC concentrations of tetracycline increased tetracycline resistance 3.9 (± 0.9)-fold, similar to that of bactobolin ( Fig. 2B) . Surprisingly, no induction of resistance was observed in the DcdeAB-oprM mutant, whereas a significant 2.7 (± 1.3)-fold increase was observed in the DcseB mutant. These results suggest CdeAB-OprM is primarily responsible for induction of tetracycline tolerance.
CseR is an activator of the cseAB-oprN genes.
Because CseR is genetically linked to CseAB-OprN, and this system is involved in induction of bactobolin tolerance, we predicted CseR is important for bactobolin tolerance. Consistent with this prediction, DcseR cells did not induce bactobolin tolerance as well as wild type, increasing the MIC by only 1.8 (± 0.7)-fold (p < 0.0005 compared with wild type induction). Surprisingly, DcseR cells were similarly impaired for induction of tetracycline tolerance. We also measured cdeA and cseA transcripts in wild type or the DcseR mutant treated with bactobolin or tetracycline, or with no antibiotic (Fig. 3) . Our results show that cseA transcription was 2.4-fold higher in bactobolin-treated cells compared with untreated cells, and the increase was dependent on cseR.
There was no change in cseA transcription in tetracycline-treated cells. These results are consistent with the idea that CseR activates transcription of the cseAB-oprN genes, and that the response is specific to bactobolin. cdeA transcription was also antibiotic inducible. We observed a 3-fold increase in cdeA transcription in cells treated with either bactobolin or tetracycline.
However, CseR was not required for the increase in cdeA transcription with either antibiotic. Our results suggest CseR has a direct role in regulating cseAB-oprN transcription in response to bactobolin antibiotic, and might also participate in regulating CdeAB-OprM in response to tetracycline.
Specificity and response to bactobolin
We found it interesting that cdeA was transcriptionally activated by bactobolin similar to cseA (Fig. 3) , but the CdeAB-OprM system was not important for bactobolin tolerance (Fig. 2) .
These results suggest bactobolin induces CdeAB-OprM system but the induction or export activity might be relatively weak. To understand the CdeAB-OprM interaction with bactobolin, we performed a cross-tolerance experiment. We incubated cells with sub-MIC bactobolin and subjected those cells to an MIC experiment with tetracycline. Our result showed that incubation with sub-MIC bactobolin increased resistance to tetracycline in a manner that was dependent on CdeAB-OprM (Fig. 4A) . These results support the conclusion that the CdeAB-OprM pump can be induced by sub-MIC bactobolin. We also incubated cells with sub-MIC concentrations of tetracycline and subjected those cells to an MIC with bactobolin. Our results showed that tetracycline induction increased resistance to bactobolin in a manner that was also dependent on the CdeAB-OprM system (Fig. 4B) . Thus, bactobolin can serve as a substrate of CdeAB-OprM, consistent with results of the MIC experiments (Table 1) . However, the induction requires tetracycline, suggesting that tetracycline induces CdeAB-OprM more strongly than bactobolin.
The results are also consistent with the conclusion from the quantitative PCR data that tetracycline specifically induces the CdeAB-OprM pump, whereas bactobolin can induce both pumps. Together, our results support that CseAB-OprN has a high level of sensitivity and specificity for bactobolin, whereas CdeAB-OprM recognizes bactobolin to a lesser degree, but can also respond to other antibiotics.
CseAB-OprN is important for induction of bactobolin resistance in a laboratory co-culture model
We used our B. thailandensis-C. subtsugae co-culture model to test the role of CseABOprN and tolerance induction during competition. In this model, B. thailandensis typically outcompetes C. subtsugae (CV017) primarily due to production of bactobolin (18) . To test the role of CseAB-OprN in the competition model, we combined exponentially growing cultures of B. thailandensis and C. subtsugae and enumerated each species after 24 h by colony counting on selective media. The results of competition with the wild-type strain was similar to previously published results: B. thailandensis outcompeted C. subtsugae and dominated the culture at the end of the experiment (Fig. 5, 'wild type,' open circles) . However, when sub-MIC bactobolin was supplied in the culture, C. subtsugae gained an advantage over B. thailandensis (Fig. 5, filled circles). These results show that sub-MIC bactobolin exposure can increase C. subtsugae competitiveness in our co-culture model. The increase in competitiveness not observed in a DcseB mutant, and thus was due to CseAB-OprN (Fig. 5, DcseB, open circles) . We observed a similar competition defect in a DcseR mutant. These results are consistent with the role of CseABOprN in the induction of bactobolin resistance, and highlight the potential role of this response in competition with other antibiotic-producing species.
DISCUSSION
In this study, we demonstrate antibiotic specificity and regulation of two efflux pumps of Chromobacterium subtsugae CV017. One of these, CseAB-OprN, had not been previously reported and is limited to the C. subtsugae species. The other, CdeAB-OprM, is widely distributed members of the Chromobacterium genus. CdeAB-OprM has a broad range of specificity for antibiotics such as tetracycline, erythromycin, chloramphenicol and ciprofloxacin. As ciprofloxacin is one of the recommended treatments for infections with pathogenic Chromobacterium (2), the results suggest this pump might be important in cases of antibiotic failures. To date, there are very few publications on Chromobacterium mechanisms of antibiotic resistance and drug export (18, 22, 23) . Results of this study will be useful for identifying resistance mechanisms in clinical isolates and for future Chromobacterium research.
Our results demonstrate that both CdeAB-OprM and CseAB-OprN are induced by their antibiotics substrates. Such a response is typical of other pumps such as the aminoglycosideresponsive MexXY pump of Pseudomonas aeruginosa (24) and the trimethoprim-responsive BpeEF-OprC pump of Burkholderia pseudomallei (25) . Because many antibiotic resistance factors are costly to produce, waiting to induce their production until needed might allow a valuable metabolic cost savings (26) . The ability to respond to antibiotic stress might be an important survival strategy in infected patients undergoing antibiotic therapy (27) , and, as highlighted by our co-culture model, such responses might also be important during competition with other bacteria.
Competitive interactions with other bacteria might also be an important factor shaping the evolution of antibiotic production. Many antibiotics are regulated by quorum sensing in response to changes in population density, for example B. thailandensis bactobolin is regulated by the BtaR2-I2 quorum sensing system (28) . Quorum sensing regulation of antibiotics might be a strategy to avoid tolerance induction of competitors (29) . By waiting to produce antibiotic until high density, the population is able to produce a sudden dose of antibiotic to kill the competitor.
Quorum-sensing regulation delays the production of bactobolin until the population reaches stationary phase (30) . This growth stage occurs around 12 hr in our co-culture model (18) . We were able to induce antibiotic tolerance of C. subtsugae by adding sub-MIC bactobolin to the coculture at the start of the experiment. These results highlight how delaying antibiotic production until a sufficient killing dose can be produced might be useful to avert tolerance induction in competitors.
Our initial attempt to determine the phylogeny of the members of the Chromobacterium genus by 16S sequences provided a limited view of the relationships between the species. The alternative method of determining phylogeny with a set of 140 orthologous proteins provided a much higher level of confidence of relationship predictions. Using this method, we were able to validate the new classification of strain CV017 as a C. subtsugae strain. We were also able to group each of the previously unspecified strains with close relatives to assign likely species to these strains. The phylogenetic tree we generated suggests the Chromobacterium genus can be separated into three distinct groups. First is the C. haemolyticum group, a pathogenic species with a pronounced ability to haemolyze human erythrocytes (31), second is a group of nonpathogens including C. subtsugae and C. sphagnii, and third is a group including C. violaceum, C. piscinae, C. amazonense, C. vaccinnii, and C. pseudoviolaceum. Although the pathogenic ability of C. violaceum has been reported, the other members of this group were isolated from soil and water environments and their virulence potential remains unclear.
Our phylogenetic analysis suggests that the cseAB-oprN genes were acquired through horizontal transfer of the cdeAB-oprM cluster from another species, rather than through duplication of the cdeAB-oprM genes already in the ancestral strain (Fig. 1A and S1 ). The finding that horizontal transfer of resistance genes occurred in saprophytic species supports the idea that horizontal transfer can lead to the dissemination of antibiotic resistance genes in polymicrobial communities of the soil (32) . The spread of resistance might have been helpful for surviving antibiotics produced by other bacteria in the soil. The acquisition of new resistance genes might also promote tolerance to self-produced antibiotics (33) . Chromobacterium is known to produce an arsenal of antimicrobial-active molecules (34), although many have not been well characterized. The hypothesis that CseAB-OprN or CdeAB-OprM provides resistance to a selfproduced antibiotic can be tested experimentally, and such a line of experimental questioning might shed light on how antibiotic resistance mechanisms and their regulatory circuits evolve in multispecies communities.
MATERIALS AND METHODS
Bacterial culture conditions and strains. All strains were grown in Luria-Bertani (LB) broth, LB containing morpholine-propanesulfonic acid (LB-MOPS; 50 mM; pH 7), or on LB with 1.5% (wt/vol) Bacto-Agar. All broth cultures were incubated with shaking at 30°C (C. subtsugae or C. subtsugae-B. thailandensis co-cultures) or 37°C (B. thailandensis or E. coli). As a source of bactobolin, we used filtered B. thailandensis culture fluid prepared as described previously (18) . Filtered B. thailandensis culture fluid was stored at 4°C for up to 1 month prior to use and used directly for experiments. For strain constructions, we used gentamicin at 50 μg ml−1 (C. subtsugae) or 15 μg ml−1 (E. coli). For selection from co-cultures we used gentamicin at 100 μg ml−1 (B. thailandensis) and trimethoprim at 100 μg ml−1 (C. subtsugae).
Bacterial strains and plasmids used in this study are listed in Tables S1-S3. For co-cultures, we used the wild-type B. thailandensis strain E264 (35) . C. subtsugae strain CV017 (referred to as wild type, previously known as C. violaceum CV017) is a derivative of strain ATCC31532 (36) with a transposon insertion in gene CV_RS05185 causing overexpression of violacein (37, 38) . All C. subtsugae mutant strains were constructed from CV017 using allelic exchange and methods described previously (16) . The constructs for generating deletions in cseB, cdeR and cseR were made by introducing PCR-generated amplicons or synthetic gene fragments (IDT or Genscript) into pEX18Gm-derived delivery plasmid (39) . The mutation was introduced to C. subtsugae by conjugation and transconjugants were selected on gentamicin. Transconjugants were transferred to no salt-LB + 15 % sucrose to select for plasmid excision and correct clones were identified by PCR-based screening. All strains and PCR-generated plasmids were verified by PCR amplification and sequencing.
Phylogeny of Chromobacterium species and efflux pump genes. Chromobacterium species used for phylogenetic analyses are listed in Table S3 . Annotated protein sequences from assembled genomes of Chromobacterium and Aquitaliea magnusonii (outgroup) were retrieved from the National Center for Biotechnology Information (NCBI, June 2018, Table S3 ). Comparisons using 16S rRNA provided low confidence predictions of phylogeny, thus we performed an analysis using a set of 140 single-copy orthologs, which were identified using several steps. Orthologous proteins were initially identified by using blastp to carry out reciprocal best blast hits of each protein from each strain against a protein database made of all the proteins in our strain set ( (40), options: -max_target_seqs 1), to find orthologs with best blast hit between all possible pairs of species, and no more than 10% variation in protein length. We aligned this group of 171 proteins individually using Muscle version 3.8.31 ( (41), options -diags), then reordered sequences using the stable.py script provided by the Muscle developer. Finally, we removed any orthologous protein groups with less than 75% average pairwise identity, less than 30% of sites identical or 100% of sites identical. This last step ensured that all proteins would have intermediate levels of divergence and left the final set of 140 orthologs used for phylogenetic tree construction. Finally, we concatenated the protein sequences in each alignment to create one single alignment consisting of 25,351 amino acids. After inspection of this alignment, we found that several pairs of isolates had very low divergence (less than 10 amino acid differences across the entire alignment). We decided to remove one of each of these pairs to reduce redundancy (removed isolates were C. violaceum strains LK6, LK30, H5525 and 16-419B). C. subtsugae F49 and C. subtsugae CV017 are identical across the alignment of orthologous proteins but both were retained because CV017 is the focus of the paper.
We generated phylogenetic trees using neighbor joining, maximum likelihood and Bayesian methods. A simple neighbor joining (NJ) tree implemented in Geneious version 10.1.3 (http://www.geneious.com) with a Jukes-Cantor substitution model and 100 bootstrap replicates and A. magnusonii as an outgroup. We constructed a maximum likelihood tree using RaxML version 8.2.11 (42) with a Gamma BLOSSUM62 protein model, 100 bootstrap replicates with a parsimony random seed of 1 and A. manusonii as an outgroup. We used Mr. Bayes version 3.2.6 (43) to construct a tree using Bayesian methods with a Poisson rate matrix, gamma rate variation with 4 categories, and A. manusonii as an outgroup, an initial chain length of 1,100,000 with four heated chains at a temperature of 0.2, the subsampling frequency was 2000 generations after an initial burn-in length of 100,000 generations. However, after 332,000 generations, the standard deviation of split frequencies was less than 0.01 and so the tree search was terminated.
For all three methods, consensus trees were built based on 50% majority rule, and the three trees were compared using the RaxML maximum likelihood tree as a backbone.
We elected to use a concatenated sequence to build our tree because our concern is about the overall evolutionary history of the genus and not how specific genes trees might differ from species tree.
To reconstruct the evolutionary history of the two efflux pumps, we compared DNA sequence of the pump genes to improve our ability to resolve evolutionary distances between closely related isolates. We retrieved the DNA sequences by performing a tblastn (44) of the amino acid sequence for that protein against all Chromobacterium genome assemblies and then located the correct sequence based on isolate name. Note that one sequence was split among two scaffolds in C. subtsugae MWU2387 and was therefore not annotated so we pieced together the appropriate sequence. To find orthologs of the second pump (cseB) we performed a tblastn search of the amino acid sequence of CdeB from CV017 against all assembled Chromobacterium species.
Reciprocal best blast searches confirmed the presence of this second pump in only a subset of the C. subtsugae isolates (including CV017). We also searched for similar sequences outside of Chromobacterium to find evidence for horizontal transfer of the pump. Finally, we constructed phylogenetic trees of the DNA sequence for the two pumps similar to what was described above but with nucleotides instead of amino acids. To assess changes in MIC induced by exposure to sub-lethal antibiotic (tolerance), logarithmic-phase C. subtsugae cells were diluted to an OD600 of 0.1 in 10 ml LB-MOPS in a 125-ml culture flask. The culture medium contained antibiotic at ½ of the MIC determined by the method described above (this varied for each strain), or no antibiotic (untreated), and incubated for 6 hours with shaking at 30°C. These cultures were then directly used to determine MIC using methods described above.
Droplet digital PCR. RNA was harvested from C. violaceum as described in the figure legends. RNA was prepared using the RNeasy® Mini Kit (Qiagen) following the manufacturer instruction with a modification in the DNA digestion step as described previously (18) . Droplet digital PCR was performed on a Bio-Rad's QX200 Droplet Digital PCR (ddPCR) System using Eva Green Supermix. Each reaction mixture contained 1 ng sec. Absolute transcript levels were determined using the Bio-Rad QuantaSoft Software.
In all cases a no template control was run with no detectable transcripts.
Co-culture experiments. Co-culture experiments were conducted in 10 ml LB-MOPS medium in 125 ml baffled flasks. The inoculum was from logarithmic-phase pure cultures of C. subtsugae and B. thailandensis. The initial OD600 in the co-culture was 0.05 for B.
thailandensis (2-4x10 7 cells per ml) and 0.005 for C. subtsugae (2-4x10 6 cells per ml).
When indicated, cultures also contained B. thailandensis culture fluid at a concentration corresponding with ½ of the MIC for the C. subtsugae strain used in the experiment. After inoculating, co-cultures were incubated at 30ºC with shaking at 230 r.p.m for 24 h. Colony forming units of each species were determined by using differential antibiotic selection on LB agar plates. B. thailandensis was selected with gentamicin and C. subtsugae was selected with trimethoprim. Table 1 .
Final MIC is shown as the average and standard error of 3-4 biological replicates for each strain.
*, statistical significance by t-test; *, P < 0.03. 
